The grading of lymphovascular space invasion in endometrial carcinoma

被引:2
|
作者
Hachisuga, T
Kaku, T
Fukuda, K
Eguchi, F
Emoto, M
Kamura, T
Iwasaka, T
Kawarabayashi, T
Sugimori, H
Mori, M
机构
[1] Fukuoka Univ, Sch Med, Dept Obstet & Gynecol, Jonan Ku, Fukuoka 8140180, Japan
[2] Kyushu Univ, Sch Med, Dept Obstet & Gynecol, Fukuoka 812, Japan
[3] Saga Med Sch, Dept Obstet & Gynecol, Saga, Japan
[4] Saga Med Sch, Dept Community Hlth Sci, Saga, Japan
关键词
endometrial carcinoma; lymphovascular space invasion; prognosis; lymph node metastasis;
D O I
10.1002/(SICI)1097-0142(19991115)86:10<2090::AID-CNCR29>3.0.CO;2-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BAGKGROUND. This study was conducted to elucidate the prognostic significance of a three-grade system for lymphovascular space invasion (LVSI). METHODS. The prognostic significance of the grading of LVSI as compared with other pathologic variables was evaluated in a study of 303 Japanese women with endometrial carcinoma. The criteria for determining the grade of LVSI were as follows: none (no LVSI), mild (a focus of LVSI was recognized around a turner), and severe (diffuse or multifocal LVSI were recognized around the tumor or in the myometrium regardless of the degree of myometrial invasion). Both univariate and multivariate regression analyses were performed. The effects of different surgical methods and adjuvant therapies on survival were also examined. RESULTS. A univariate survival analysis showed that survival significantly correlated with surgical stage, histologic grade, depth of myometrial invasion, LVSI, cervical invasion, ovarian metastasis, and tubal metastasis. Of the three grades of LVSI, survival showed the most difference between the mild and severe groups. In multivariate analysis, the highest correlation with survival was observed for LVSI (P = 0.0008). Lymph node metastasis was also significantly associated with LVSI (P = 0.0001). The correlation between histologic variables and survival was only slightly influenced by the differences in surgical methods and adjuvant therapies. CONCLUSIONS. The grading of LVSI was found to be an important histologic prognostic variable. The severe degree of LVSI also was found to be a good indicator of lymph node metastasis. It is therefore important to evaluate the grade of LVSI based on a histologic examination of at least one cut surface of the hysterectomy specimen that macroscopically shows the deepest myometrial invasion. Cancer 1999;86:2090-7. (C) 1999 American Cancer Society.
引用
收藏
页码:2090 / 2097
页数:8
相关论文
共 50 条
  • [41] Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer
    Ayhan, Ali
    Sahin, Hanifi
    Sari, Mustafa Erkan
    Yalcin, Ibrahim
    Haberal, Ali
    Meydanli, Mehmet Mutlu
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (03) : 505 - 512
  • [42] Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer?
    Meydanli, Mehmet M.
    Aslan, Koray
    Oz, Murat
    Muftuoglu, Kamil H.
    Yalcin, Ibrahim
    Engin-Ustun, Yaprak
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2020, 39 (03) : 213 - 220
  • [43] Does Robotic Hysterectomy Increase the Incidence of Lymphovascular Space Invasion in Endometrial Cancer?
    Alosh, B.
    Shi, D.
    Al-Wahab, Z.
    Bandyopadhyay, S.
    Arabi, H.
    Morris, R.
    Salem, N.
    Ali-Fehmi, R.
    MODERN PATHOLOGY, 2013, 26 : 264A - 265A
  • [44] Does Robotic Hysterectomy Increase the Incidence of Lymphovascular Space Invasion in Endometrial Cancer?
    Alosh, B.
    Shi, D.
    Al-Wahab, Z.
    Bandyopadhyay, S.
    Arabi, H.
    Morris, R.
    Salem, N.
    Ali-Fehmi, R.
    LABORATORY INVESTIGATION, 2013, 93 : 264A - 265A
  • [45] IS IT POSSIBLE TO DEVELOP A PREDICTION MODEL FOR LYMPHOVASCULAR SPACE INVASION IN ENDOMETRIOID ENDOMETRIAL CANCER?
    Meydanli, M. M.
    Aslan, K.
    Oz, M.
    Muftuoglu, K. H.
    Yalcin, I.
    Engin-Ustun, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A345 - A346
  • [46] Lymphovascular Space Invasion (LVSI) to Guide Adjuvant Treatment in Endometrial Carcinoma (EC) - Assessment with and without the Use of Vascular Markers
    Meyer, Charlotte
    Grube, Marcel
    Greif, Karen
    Praetorius, Teresa
    Kommoss, Friedrich
    Gilks, C. Blake
    Staebler, Annette
    Kommoss, Stefan
    Singh, Naveena
    LABORATORY INVESTIGATION, 2023, 103 (03) : S952 - S953
  • [47] MRI-based traditional radiomics and computer-vision nomogram for predicting lymphovascular space invasion in endometrial carcinoma
    Long, Ling
    Sun, Jianqing
    Jiang, Liling
    Hu, Yixin
    Li, Lan
    Tan, Yong
    Cao, Meimei
    Lan, Xiaosong
    Zhang, Jiuquan
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2021, 102 (7-8) : 455 - 462
  • [48] The significance of lymphovascular space invasion in microinvasive squamous cell carcinoma of the vulva
    Ricciuti, J.
    Boisen, M. M.
    Kelley, J. L., III
    Taylor, S. E.
    Sukumvanich, P.
    Berger, J.
    Orr, B. C.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 209 - 209
  • [49] Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer
    Hahn, Ho-Suap
    Lee, In-Ho
    Kim, Tae-Jin
    Lee, Ki-Heon
    Shim, Jae-Uk
    Kim, Jae-Wook
    Lim, Kyung-Taek
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2013, 53 (03): : 293 - 297
  • [50] Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
    Beavis, Anna L.
    Yen, Ting-Tai
    Stone, Rebecca L.
    Wethington, Stephanie L.
    Carr, Caitlin
    Son, Ji
    Chambers, Laura
    Michener, Chad M.
    Ricci, Stephanie
    Burkett, Wesley C.
    Richardson, Debra L.
    Staley, Allison-Stuart
    Ahn, Susie
    Gehrig, Paola A.
    Torres, Diogo
    Dowdy, Sean C.
    Sullivan, Mackenzie W.
    Modesitt, Susan C.
    Watson, Catherine
    Veade, Ashely
    Ehrisman, Jessie
    Havrilesky, Laura
    Secord, Angeles Alvarez
    Loreen, Amy
    Griffin, Kaitlyn
    Jackson, Amanda
    Viswanathan, Akila N.
    Jager, Leah R.
    Fader, Amanda N.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 568 - 574